The glucoregulatory action of glucagon-like peptide-1 (GLP-1).

Malgorzata. Adamczyk
Glucagon-like peptide-1 (GLP-1) has been shown to improve tolerance to glucose. It has been suggested that this could be mediated by an incretin effect--the enhancement of insulin secretion in response to glucose, as well as by alterations in the sensitivity of the body to insulin. In order to evaluate the effect of GLP-1 on the improvement of glucose tolerance, the systemic as well as tissue-specific (the liver, intestine and muscle) effects of this hormone have...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.